Loading...
Tenova Pharmaceuticals | SKU:
T55057-5mg
Inavolisib
Regular price
£368.97
Unit price
/
Unavailable
Inavolisib - 5mg is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Sign up to be the first to know when this product is in stock
Inavolisib (GDC-0077) is a potent, orally available, and selective PI3Ka inhibitor (IC50=0.038 nM).
| Product Name | Inavolisib |
| Synonyms | GDC-0077 |
| CAS Number | 2060571-02-8 |
| Related CAS | |
| Molecular Formula | C18H19F2N5O4 |
| Molecular Weight | 407.378 |
| SMILES | C[C@H](NC1=CC=C2C3=NC(=CN3CCOC2=C1)N1[C@@H](COC1=O)C(F)F)C(N)=O |
| Purity (HPLC) | >= 95% |
| Physical Appearance | White solid |
| Solubility | DMSO, DMF |
| Shipping Conditions | Room Temperature |
| Storage Conditions | Refrigerated |
| Shelf Life | 12 months after the date of delivery |
| Regulatory Statement | For Research Use Only |
References
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer. https://clinicaltrials.gov/ct2/show/NCT04191499 (accessed Mar 29, 2022).
Documents
Datasheet COA MSDS
Citations
If you know of a paper that uses this product from Tenova Pharma, please let us know.
